How Do GLP-1 Medications Help with Weight Loss
Eat slower, pay attention to satiety signals, and dont eat on the run
2025, e70103, Rentzeperi, Elpiniki, et al
We also identified several further observational investigations
In the larger SELECT trial in 2023, patients with heart failure, atherosclerotic disease, and overweight or obesity, treated with semaglutide 2.4 mg showed reduction in major adverse cardiac events (MACE) and heart failure end points regardless of heart failure subgroup being HFrEF or HFpEF [56,57,58]
This suppression occurs just at or above fasting glucose levels, hence preserving counterregulatory responses to hypoglycaemia (Holst 2007)